India declared cancer capital of the world – Apollo report

India declared cancer capital of the world - Apollo report

Share This Post

India declared cancer capital of the world

India was designated as the “cancer capital of the world” in the 4th edition of Apollo Hospitals’ Health of the Nation Report, which was published on World Health Day 2024.

According to a report by PTI, this study on India’s health situation revealed concerning patterns in non-communicable diseases (NCDs), with a significant increase in cancer incidence around the country.

As per the 4th edition of the Health of Nation Report by Apollo Hospitals, on World Health Day 2024, almost 33% of Indians have pre-diabetes, 66% have pre-hypertension, and 10% are now dealing with depression.

The research emphasizes the alarming increase of non-communicable diseases (NCDs) in India, including cancer, diabetes, hypertension, cardiovascular illnesses, and mental health disorders, all of which have a substantial impact on the country’s health. India is experiencing a significant increase in cancer cases compared to global rates, which has led to the country being referred to as the “cancer capital of the world.”

Moreover, the paper predicts a possible rise in healthcare expenses caused by illnesses such as pre-diabetes, pre-hypertension, and mental health disorders manifesting in younger individuals. The paper highlights the significance of frequent health screenings in reducing blood pressure (BP) and body mass index (BMI) levels, hence lowering the risk of cardiac-related diseases.

The prevalent cancers in India, ranked by frequency, among women are breast, cervix, and ovary, and among men, they are lung, mouth, and prostate. Nevertheless, despite the comparatively younger age at which cancer is diagnosed in India in comparison to other nations, the rates of cancer screening are still disturbingly low, as stated in the hospital’s announcement.

Health screening and unified action are the needs of the hour

The analysis underscores the need for routine health exams to mitigate the likelihood of cardiac-related illnesses through the monitoring of blood pressure and body mass index values. Although there is an increasing recognition of the need for health checks, there is still a requirement to broaden their coverage throughout India.

Dr. Preetha Reddy, Vice Chairperson of Apollo Hospitals, emphasized the significance of collectively combating non-communicable diseases (NCDs). She emphasized the necessity of nationwide endeavors to properly address these diseases through education and tailored preventative healthcare solutions.

“It is imperative for the healthcare ecosystem and the nation to unite and adopt a cohesive approach in order to effectively address non-communicable diseases.” The findings revealed a pressing requirement for prompt therapies to combat, prevent, and reverse the escalating epidemic of cancer, diabetes, hypertension, and obesity, among other conditions. According to Dr. Reddy, there is an urgent requirement to provide education to the general public and develop personalized preventative healthcare strategies.

She advocated for the prioritization of investments in health infrastructure, the promotion of preventative healthcare measures, and the resolution of health inequities, in order to facilitate sustainable development in the health sector.

Dr. Madhu Sasidhar, President and CEO of Apollo Hospitals, emphasized the need for innovation in preventive healthcare and enhanced accessibility. He stressed the importance of using technology to improve illness prevention, increase the accuracy of diagnoses, and develop patient-centered treatment methods.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

After amazing growth of CAR T-Cell therapy what's next
CAR T-Cell therapy

After amazing growth of CAR T-Cell therapy: what’s next?

CAR T-cell therapy has rapidly transformed cancer treatment by reprogramming a patient’s T-cells to attack cancer cells, demonstrating remarkable success in hematologic cancers. Advances in genetic engineering, regulatory support, and investment are driving further expansion. Researchers are now tackling the challenges of applying this therapy to solid tumors, aiming to enhance efficacy and accessibility, marking a new era in personalized cancer therapy and immunotherapy.

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS
Cancer

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate, a groundbreaking treatment, has recently received approval from the US Food and Drug Administration (FDA) for pediatric patients, marking a significant milestone in pediatric oncology. This approval represents a beacon of hope for children battling neuroendocrine tumors (NETs), a rare but challenging form of cancer that often proves resistant to conventional therapies.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy